Outcome of Board Meeting

Q1FY27 results (unaudited): Consolidated: No explicit revenue or PAT figures disclosed. FY2026 results (audited): Standalone and Consolidated results not explicitly disclosed in the filing. Dividend: Record date for dividend approved (date not specified). Commentary: The company reported no deviation or variation in the utilization of proceeds raised through the preferential allotment of Rs 300.00 crore as of June 30, 2026. Utilization included investments in wholly owned subsidiary, product development, infrastructure enhancement, strategic acquisition, and general corporate purposes. Monitoring agency CARE Ratings Limited confirmed compliance with the objects of the issue. The company incorporated a wholly owned subsidiary in Dubai and migrated to the NSE and BSE main boards during FY2026. Secretarial audit noted compliance with applicable laws except for a prior non-compliance related to in-principle approval for securities issuance, which was regularized with fines paid.